Trial intelligence / Profile preview

ONO-7018-02 single-dose and itraconazole interaction study in healthy Japanese males

jRCT2071240038Phase 1Completed

Sponsor
Ono Pharmaceutical
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of ONO-7018 (4 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Adverse events after ONO-7018 administration, Plasma ONO-7018 concentrations and pharmacokinetic parameters and 1 more. Started Aug 2024; status: completed.

02

Drugs

ONO-7018

Beyond the preview

Go deeper on jRCT2071240038.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2071240038.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call